9 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Terminated 9 |
Follow Ticagrelor: new trials by email Literature Review of Ticagrelor trials Research Report on Ticagrelor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily, Ticagrelor Monotherapy: Ticagrelor 60 mg twice daily, Personalized Therapy Arm: Aspirin 81 mg or Ticagrelor 60mg twice daily or Clopidogrel 75 mg once daily - Coronary Artery Disease, Myocardial Infarction | Phase 4 | Terminated | Ottawa Heart Institute Research Corporation | 39 | 2019-08-22 | 2026-05-06 |
| Fentanyl and Crushed Ticagrelor in Percutaneous Coronary Intervention Fentanyl, Ticagrelor 90Mg Tablet - Percutaneous Coronary Intervention | Phase 4 | Terminated | The Guthrie Clinic | 45 | 2018-04-18 | 2026-02-04 |
| A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY) Ticagrelor 60mg, Clopidogrel 75mg, Aspirin 81 mg - Stable Coronary Syndrome, Percutaneous Coronary Intervention | Phase 4 | Terminated | Ottawa Heart Institute Research Corporation | 5 | 2017-08-18 | 2019-07-19 |
| P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold Clopidogrel, Ticagrelor, Aspirin - Coronary Artery Disease, Stents | Phase 4 | Terminated | Samsung Medical Center | 25 | 2017-04-19 | 2024-04-22 |
| Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery ticagrelor, aspirin - Myocardial Injury | Phase 4 | Terminated | The Cleveland Clinic | 6 | 2015-07-01 | 2017-02-09 |
| Ticagrelor and Peripheral Arterial Disease Percutaneous Peripheral Intervention, Optical Coherence Tomography, Ankle Brachial Index - Peripheral Arterial Disease | Phase 4 | Terminated | Arkansas Heart Hospital | 26 | 2015-06-01 | 2019-01-11 |
| Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin. ticagrelor, clopidogrel - Non-ST Elevation Acute Coronary Syndrome | Phase 4 | Terminated | AstraZeneca | 34 | 2014-09-01 | 2016-05-27 |
| Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome Ticagrelor, Clopidogrel - Acute Coronary Syndrome, Acute Myocardial Infarction | Phase 4 | Terminated | Yonsei University | 148 | 2014-01-01 | 2019-03-29 |
| Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS Ticagrelor, Clopidogrel - Non ST Segment Elevation Acute Coronary Syndrome | Phase 4 | Terminated | Catholic University of the Sacred Heart | 55 | 2012-11-01 | 2016-07-26 |
Coronary Artery Disease (2) · Acute Coronary Syndrome (1) · Angina, Unstable (1) · Atherosclerosis (1) · Intermittent Claudication (1) · Myocardial Infarction (1) · Peripheral Arterial Disease (1)
Ottawa Heart Institute Research Corporation (2) · Arkansas Heart Hospital (1) · AstraZeneca (1) · Catholic University of the Sacred Heart (1) · Samsung Medical Center (1) · The Cleveland Clinic (1) · The Guthrie Clinic (1) · Yonsei University (1)
United States (4) · Canada (2) · South Korea (2) · Italy (1)
Derek So, MD (1) · Derek YF So, MD FRCPC (1) · Gerardo Rodriguez, MD PhD (1) · Hinan Ahmed, MD (1) · Joo-Yong Hahn, MD, PhD (1) · Luigi M Biasucci, Professor (1) · Marc Cohen, MD (1) · Marc D Feldman, MD (1) · Massoud Leesar, MD (1) · Mehmet Cilingiroglu, MD (1) · Venu Menon, MD (1)